Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Next-Generation Roche: How Data Analytics Will Keep It In The Lead In Oncology

Executive Summary

Roche used its ASCO investor briefing to highlight its digital and personalized healthcare strategy, including examples of how it’s facilitating R&D and reimbursement – and how that should position it to be an oncology leader in the future. 

Advertisement

Related Content

How The EHR And New Data Streams Are Influencing Clinical Practice
Roche, Bristol On The Defensive After Merck's Lung Cancer Wins At ASCO
'Watch This Space' Roche Execs Say, Outlining RWE Rationale For Flatiron Buy
Roche To Build RWE Cancer Data Extraction Role With Flatiron Buy
Roche’s Alecensa Goes Up Against Zykadia with First-Line NSCLC US FDA Approval
Roche Pushes The Boundaries Of Cancer Immunotherapy
Roche's Guide To Success In Oncology
Roche's Oncology Strategy: The Long Game Comes Into Focus
Roche Could Repeat Genentech Success With Foundation Medicine Partnership
Pharma trial needs drive Roche's $1.2bn Foundation Medicine deal

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC123231

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel